2N Pharma ApS — Credit Rating and Financial Key Figures
CVR number: 41169303
Niels Jernes Vej 10, 9220 Aalborg Øst
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | 335.88 | 1 538.09 | 2 221.90 | 543.22 |
| Employee benefit expenses | - 593.81 | -2 961.41 | -2 074.04 | - 963.97 |
| Total depreciation | -3.50 | -16.36 | -17.92 | -17.92 |
| EBIT | - 261.42 | -1 439.67 | 129.94 | - 438.68 |
| Other financial income | 17.16 | 25.92 | 1.23 | 3.48 |
| Other financial expenses | -4.27 | -82.57 | -41.28 | -56.59 |
| Pre-tax profit | - 248.53 | -1 496.32 | 89.89 | - 491.80 |
| Income taxes | 60.60 | 1 177.86 | 180.21 | 145.00 |
| Net earnings | - 187.93 | - 318.46 | 270.10 | - 346.80 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Development expenditure | 3 714.15 | 13 755.65 | 17 222.46 | 19 741.75 |
| Intangible assets total | 3 714.15 | 13 755.65 | 17 222.46 | 19 741.75 |
| Machinery and equipment | 51.99 | 101.97 | 84.94 | 67.01 |
| Tangible assets total | 51.99 | 101.97 | 84.94 | 67.01 |
| Other receivables | 10.82 | 11.32 | ||
| Investments total | 10.82 | 11.32 | ||
| Long term receivables total | ||||
| Inventories total | ||||
| Current amounts owed by group member comp. | 80.35 | 11.93 | ||
| Prepayments and accrued income | 22.81 | 33.66 | 43.82 | 32.57 |
| Current other receivables | 40.00 | 64.76 | 139.06 | 97.34 |
| Current deferred tax assets | 811.06 | 2 049.56 | 683.64 | 295.35 |
| Short term receivables total | 873.88 | 2 147.98 | 946.87 | 437.18 |
| Cash and bank deposits | 6 193.55 | 772.71 | 1 397.51 | 1 555.58 |
| Cash and cash equivalents | 6 193.55 | 772.71 | 1 397.51 | 1 555.58 |
| Balance sheet total (assets) | 10 833.56 | 16 778.31 | 19 662.59 | 21 812.85 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 2 897.04 | 2 897.04 | 13 433.52 | 15 398.56 |
| Retained earnings | -2 897.04 | 6 244.26 | -2 695.57 | -4 390.52 |
| Profit of the financial year | - 187.93 | - 318.46 | 270.10 | - 346.80 |
| Shareholders equity total | - 147.93 | 8 862.84 | 11 048.05 | 10 701.25 |
| Provisions | 750.47 | 1 622.17 | 2 125.59 | 2 275.94 |
| Non-current loans from credit institutions | 9 952.00 | 5 749.69 | 6 029.38 | 6 505.14 |
| Non-current deferred tax liabilities | 10.63 | |||
| Non-current liabilities total | 9 962.63 | 5 749.69 | 6 029.38 | 6 505.14 |
| Current trade creditors | 166.59 | 143.65 | 355.93 | 449.49 |
| Other non-interest bearing current liabilities | 101.81 | 399.97 | 103.64 | 47.72 |
| Accruals and deferred income | 1 833.32 | |||
| Current liabilities total | 268.40 | 543.62 | 459.57 | 2 330.53 |
| Balance sheet total (liabilities) | 10 833.56 | 16 778.31 | 19 662.59 | 21 812.85 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.